PREVNAR 20™

BIOLOGICAL3 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Healthy

Phase 1

A Study of V118 Formulation C (V118C) in Healthy Participants (V118C-001)

CompletedNCT06611033

Merck Sharp & Dohme LLCHealthy

Start: 2024-09-25End: 2026-01-09Updated: 2026-01-20

A Study of V118E in Healthy Participants (V118E-003)

RecruitingNCT07168915

Merck Sharp & Dohme LLCHealthy

Start: 2025-10-08End: 2027-07-06Target: 126Updated: 2026-07-15

A Study of V132 in Healthy Older Participants (V132-001)

RecruitingNCT07712575

Merck Sharp & Dohme LLCHealthy

Start: 2026-08-12End: 2028-06-21Target: 280Updated: 2026-09-02